195 related articles for article (PubMed ID: 24500755)
1. High-sensitivity PCR method for detecting BRAF V600E mutations in metastatic colorectal cancer using LNA/DNA chimeras to block wild-type alleles.
Chen D; Huang JF; Xia H; Duan GJ; Chuai ZR; Yang Z; Fu WL; Huang Q
Anal Bioanal Chem; 2014 Apr; 406(9-10):2477-87. PubMed ID: 24500755
[TBL] [Abstract][Full Text] [Related]
2. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Specificity of BRAF V600E Genotyping Using Wild-Type Blocker Coupled with Internal Competitive Reference in a Single Tube.
Peng J; Wei K; Yu S; Yang X; Zhao X; Liu Y; Zhu XY; Zhao N; Huang Q; Fu WL
Clin Lab; 2017 Oct; 63(10):1731-1740. PubMed ID: 29035465
[TBL] [Abstract][Full Text] [Related]
4. Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.
Huang JF; Zeng DZ; Duan GJ; Shi Y; Deng GH; Xia H; Xu HQ; Zhao N; Fu WL; Huang Q
PLoS One; 2015; 10(12):e0145698. PubMed ID: 26701781
[TBL] [Abstract][Full Text] [Related]
5. BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.
Roma C; Rachiglio AM; Pasquale R; Fenizia F; Iannaccone A; Tatangelo F; Antinolfi G; Parrella P; Graziano P; Sabatino L; Colantuoni V; Botti G; Maiello E; Normanno N
Cancer Biol Ther; 2016 Aug; 17(8):840-8. PubMed ID: 27261210
[TBL] [Abstract][Full Text] [Related]
6. Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer.
Dono M; Massucco C; Chiara S; Sonaglio C; Mora M; Truini A; Cerruti G; Zoppoli G; Ballestrero A; Truini M; Ferrarini M; Zupo S
Mol Med; 2013 Feb; 18(1):1519-26. PubMed ID: 23255073
[TBL] [Abstract][Full Text] [Related]
7. BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.
Ilie MI; Long-Mira E; Hofman V; Mouroux J; Vignaud JM; Gauchotte G; Begueret H; Merlio JP; Emile JF; Hébuterne X; Hofman P
Pathology; 2014 Jun; 46(4):311-5. PubMed ID: 24798160
[TBL] [Abstract][Full Text] [Related]
8. Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E.
Jarry A; Masson D; Cassagnau E; Parois S; Laboisse C; Denis MG
Mol Cell Probes; 2004 Oct; 18(5):349-52. PubMed ID: 15294323
[TBL] [Abstract][Full Text] [Related]
9. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.
Bösmüller H; Fischer A; Pham DL; Fehm T; Capper D; von Deimling A; Bonzheim I; Staebler A; Fend F
Hum Pathol; 2013 Mar; 44(3):329-35. PubMed ID: 23089489
[TBL] [Abstract][Full Text] [Related]
10. Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients.
Pinzani P; Salvianti F; Cascella R; Massi D; De Giorgi V; Pazzagli M; Orlando C
Clin Chim Acta; 2010 Sep; 411(17-18):1319-24. PubMed ID: 20576522
[TBL] [Abstract][Full Text] [Related]
11. Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues.
Chat-Uthai N; Vejvisithsakul P; Udommethaporn S; Meesiri P; Danthanawanit C; Wongchai Y; Teerapakpinyo C; Shuangshoti S; Poungvarin N
PLoS One; 2018; 13(6):e0198795. PubMed ID: 29879227
[TBL] [Abstract][Full Text] [Related]
12. The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer.
Mancini I; Santucci C; Sestini R; Simi L; Pratesi N; Cianchi F; Valanzano R; Pinzani P; Orlando C
J Mol Diagn; 2010 Sep; 12(5):705-11. PubMed ID: 20616366
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Detection and Resolution of BRAF V600 Status in Colorectal Cancer Using Droplet Digital PCR and a Novel Wild-Type Negative Assay.
Bidshahri R; Attali D; Fakhfakh K; McNeil K; Karsan A; Won JR; Wolber R; Bryan J; Hughesman C; Haynes C
J Mol Diagn; 2016 Mar; 18(2):190-204. PubMed ID: 26762843
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of the BRAF
Ashida A; Sakaizawa K; Mikoshiba A; Uhara H; Okuyama R
Int J Clin Oncol; 2016 Oct; 21(5):981-988. PubMed ID: 27041702
[TBL] [Abstract][Full Text] [Related]
15. Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients.
Barbano R; Pasculli B; Coco M; Fontana A; Copetti M; Rendina M; Valori VM; Graziano P; Maiello E; Fazio VM; Parrella P
Sci Rep; 2015 Dec; 5():18592. PubMed ID: 26690267
[TBL] [Abstract][Full Text] [Related]
16. Sensitive electrochemical analysis of BRAF V600E mutation based on an amplification-refractory mutation system coupled with multienzyme functionalized Fe3O4/Au nanoparticles.
Situ B; Cao N; Li B; Liu Q; Lin L; Dai Z; Zou X; Cai Z; Wang Q; Yan X; Zheng L
Biosens Bioelectron; 2013 May; 43():257-63. PubMed ID: 23321558
[TBL] [Abstract][Full Text] [Related]
17. BRAF V600E Mutations in Endometrial Adenocarcinoma.
He M; Breese V; Hang S; Zhang C; Xiong J; Jackson C
Diagn Mol Pathol; 2013 Mar; 22(1):35-40. PubMed ID: 23370429
[TBL] [Abstract][Full Text] [Related]
18. ARMS-PCR for detection of BRAF V600E hotspot mutation in comparison with Real-Time PCR-based techniques.
Machnicki MM; Glodkowska-Mrowka E; Lewandowski T; Ploski R; Wlodarski P; Stoklosa T
Acta Biochim Pol; 2013; 60(1):57-64. PubMed ID: 23460942
[TBL] [Abstract][Full Text] [Related]
19. Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.
Azuara D; Santos C; Lopez-Doriga A; Grasselli J; Nadal M; Sanjuan X; Marin F; Vidal J; Montal R; Moreno V; Bellosillo B; Argiles G; Elez E; Dienstmann R; Montagut C; Tabernero J; Capellá G; Salazar R
Mol Cancer Ther; 2016 May; 15(5):1106-12. PubMed ID: 27037411
[TBL] [Abstract][Full Text] [Related]
20. Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.
Ros J; Matito J; Villacampa G; Comas R; Garcia A; Martini G; Baraibar I; Saoudi N; Salvà F; Martin Á; Antista M; Toledo R; Martinelli E; Pietrantonio F; Boccaccino A; Cremolini C; Dientsmann R; Tabernero J; Vivancos A; Elez E
Ann Oncol; 2023 Jun; 34(6):543-552. PubMed ID: 36921693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
